BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sydor S, Jafoui S, Wingerter L, Swoboda S, Mertens JC, Gerken G, Canbay A, Paul A, Fingas CD. Bcl-2 degradation is an additional pro-apoptotic effect of polo-like kinase inhibition in cholangiocarcinoma cells. World J Gastroenterol 2017; 23(22): 4007-4015 [PMID: 28652654 DOI: 10.3748/wjg.v23.i22.4007]
URL: https://www.wjgnet.com/1007-9327/full/v23/i22/4007.htm
Number Citing Articles
1
Aijun Yu, Luwen Zhao, Qingmin Kang, Jian Li, Kai Chen, Hua Fu. Transcription factor HIF1α promotes proliferation, migration, and invasion of cholangiocarcinoma via long noncoding RNA H19/microRNA-612/Bcl-2 axisTranslational Research 2020; 224: 26 doi: 10.1016/j.trsl.2020.05.010
2
Chutipa Chiawpanit, Suthida Panwong, Nunghathai Sawasdee, Pa-thai Yenchitsomanus, Aussara Panya. Genistein Sensitizes Human Cholangiocarcinoma Cell Lines to Be Susceptible to Natural Killer CellsBiology 2022; 11(8): 1098 doi: 10.3390/biology11081098
3
Zhi‐Gao Hu, Chao‐Wen Zheng, Hui‐Zhao Su, Yong‐Lian Zeng, Cheng‐Jie Lin, Zhen‐Ya Guo, Fu‐Di Zhong, Guan‐Dou Yuan, Song‐Qing He. MicroRNA‐329‐mediated PTTG1 downregulation inactivates the MAPK signaling pathway to suppress cell proliferation and tumor growth in cholangiocarcinomaJournal of Cellular Biochemistry 2019; 120(6): 9964 doi: 10.1002/jcb.28279
4
G Sun, X Wang, T Li, S Qu, J Sun. Taurine attenuates acrylamide-induced apoptosis via a PI3K/AKT-dependent mannerHuman & Experimental Toxicology 2018; 37(12): 1249 doi: 10.1177/0960327118765335
5
Pornpattra Maphanao, Raynoo Thanan, Watcharin Loilome, Sirinart Chio-Srichan, Molin Wongwattanakul, Chadamas Sakonsinsiri. Synchrotron FTIR microspectroscopy revealed apoptosis-induced biomolecular changes of cholangiocarcinoma cells treated with ursolic acidBiochimica et Biophysica Acta (BBA) - General Subjects 2020; 1864(12): 129708 doi: 10.1016/j.bbagen.2020.129708
6
Öykü Gönül Geyik, Giulia Anichini, Engin Ulukaya, Fabio Marra, Chiara Raggi. DNA Damage Response Inhibitors in Cholangiocarcinoma: Current Progress and PerspectivesCells 2022; 11(9): 1463 doi: 10.3390/cells11091463